Medpace Holdings, Inc. Letters of Credit Outstanding, Amount
Medpace Holdings, Inc. (MEDP) had Letters of Credit Outstanding, Amount of $100.00 thousand as of 2024-06-30, per its 10-Q filed 2024-07-23.
Discontinued › Notes
us-gaap:LettersOfCreditOutstandingAmount · last filed 2024-07-23
- 2024-06-30: Letters of Credit Outstanding, Amount $100.00K.
- 2024-03-31: Letters of Credit Outstanding, Amount $100.00K.
- 2023-12-31: Letters of Credit Outstanding, Amount $100.00K.
- 2023-09-30: Letters of Credit Outstanding, Amount $100.00K.
| Period end | Letters of Credit Outstanding, Amount |
|---|---|
| 2024-06-30 | $100.00K 10-Q · filed 2024-07-23 |
| 2024-03-31 | $100.00K 10-Q · filed 2024-04-23 |
| 2023-12-31 | $100.00K 10-Q · filed 2024-07-23 |
| 2023-09-30 | $100.00K 10-Q · filed 2023-10-24 |
| 2023-06-30 | $200.00K 10-Q · filed 2023-07-25 |
| 2023-03-31 | $200.00K 10-Q · filed 2023-04-25 |
| 2022-09-30 | $200.00K 10-Q · filed 2022-10-25 |
| 2022-06-30 | $200.00K 10-Q · filed 2022-07-26 |
| 2022-03-31 | $200.00K 10-Q · filed 2022-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |